AXIM Biotechnologies, Inc. (AXIM)
OTCMKTS · Delayed Price · Currency is USD
0.0110
-0.0005 (-4.35%)
Mar 5, 2026, 11:07 AM EST
AXIM Biotechnologies Revenue
AXIM Biotechnologies had revenue of $17.48K in the quarter ending June 30, 2024, with 76.04% growth. This brings the company's revenue in the last twelve months to $92.90K, up 257.95% year-over-year. In the year 2023, AXIM Biotechnologies had annual revenue of $39.52K with 345.27% growth.
Revenue (ttm)
92.90K
Revenue Growth
+257.95%
P/S Ratio
43.00
Revenue / Employee
13.27K
Employees
7
Market Cap
3.99M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 39.52K | 30.64K | 345.27% |
| Dec 31, 2022 | 8.88K | -51.59K | -85.32% |
| Dec 31, 2021 | 60.46K | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | - | - | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| LakeShore Biopharma | 84.75M |
| Clearside Biomedical | 3.33M |
| Orgenesis | 899.00K |
| Vaccinex | 601.00K |
| GPL Holdings | 376.54K |
| Enzon Pharmaceuticals | 26.00K |